Financial Conflict of Interest Policy

Financial Conflict of Interest in Research (“FCOIR”) means a significant financial interest that could directly, and significantly, affect the design, conduct, or reporting of Research, as determined by MAX BioPharma (MBP).

This could involve situations in which an employee has a relationship with an outside organization or has an opportunity that influences their personal gain (directly or indirectly) as well as adversely impacts MBP in some way shape or form.

There are numerous situations where a conflict of interest could arise and impact your vested interest in being a MBP employee, but this guide will specifically focus on research transparency involving scientific publications. For more detailed explanations, please see below.

For a more detailed guide of MAX BioPharma’s Policy on COIs, please see here. Additionally, the Office of Contracts and Grants (Gonzalo Payan, Grants & Compliance Coordinator, Email: gpayan@maxbiopharma.com, Phone 424-581-6025) can provide specialized assistance in dealing with COI depending on the circumstance.  For a Public request on an individual’s Financial Conflict of Interest, click here.

In terms of scientific publishing, many journals require a conflict / declaration of interest statement to address if there is a potential situation where the authors may have personal or financial gain with the indicated publication. These typically consist of consultation fees, being an advisor for a commercial company, involvement in associated stocks / shares with a specific company, and involvement with associated patents / commercial technological advances and related royalties